Phosphorylcholine-Targeting Immunization Reduces Atherosclerosis

Journal of the American College of Cardiology

Volumn 50, Issue 6, 2007, Pages 540-546

  Caligiuri, Giuseppina ^a   Khallou Laschet, Jamila ^a   Vandaele, Marta ^a   Gaston, Anh Thu ^a   Delignat, Sandrine ^a   Mandet, Chantal ^a   Kohler, Heinz V ^b   Kaveri, Srini V ^a   Nicoletti, Antonino ^a  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b Immpheron   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KEYHOLE LIMPET HEMOCYANIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; PHOSPHORYLCHOLINE; PHOSPHORYLCHOLINE ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; FLOW CYTOMETRY; FOAM CELL; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MORPHOMETRICS; MOUSE; NONHUMAN; PERITONEUM CELL; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPLEEN CELL; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; ATHEROSCLEROSIS; B-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HEMOCYANIN; IMMUNE SERA; IMMUNIZATION, PASSIVE; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, KNOCKOUT; PHOSPHORYLCHOLINE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 34547189707     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.11.054     Document Type: Article

References (29)

1. Steinberg D., and Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation 95 (1997) 1062-1071
2. Palinski W., Miller E., and Witztum J.L. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci U S A 92 (1995) 821-825
3. Zhou X., Caligiuri G., Hamsten A., Lefvert A.K., and Hansson G.K. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 21 (2001) 108-114
4. Zhou X., Robertson A.K., Rudling M., Parini P., and Hansson G.K. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Circ Res 96 (2005) 427-434
5. Fredrikson G.N., Soderberg I., Lindholm M., et al. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler Thromb Vasc Biol 23 (2003) 879-884
6. Hörkkö S., Bird D.A., Miller E., et al. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 103 (1999) 117-128
7. Caligiuri G., Rudling M., Ollivier V., et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 9 (2003) 10-17
8. Gupta S., Pablo A.M., Jiang X.C., Wang N., and Schindler C. IFN-gamma potentiates atherosclerosis in apoE knock-out mice. J Clin Invest 99 (1997) 2752-2761
9. Laurat E., Poirier B., Tupin E., et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 104 (2001) 197-202
10. Lee T.S., Yen H.C., Pan C.C., and Chau L.Y. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 19 (1999) 734-742
11. Nicoletti A., Paulsson G., Caligiuri G., Zhou X., and Hansson G.K. Induction of neonatal tolerance to oxidized lipoprotein reduces atherosclerosis in ApoE knockout mice. Mol Med 6 (2000) 283-290
12. Tupin E., Nicoletti A., Elhage R., et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med 199 (2004) 417-422
13. Zhou X., Nicoletti A., Elhage R., and Hansson G.K. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102 (2000) 2919-2922
14. Major A.S., Fazio S., and Linton M.F. B-Lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 22 (2002) 1892-1898
15. Caligiuri G., Nicoletti A., Poirier B., and Hansson G.K. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 109 (2002) 745-753
16. Wardemann H., Boehm T., Dear N., and Carsetti R. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J Exp Med 195 (2002) 771-780
17. Binder C.J., Horkko S., Dewan A., et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 9 (2003) 736-743
18. Chang M.K., Binder C.J., Torzewski M., and Witztum J.L. C-Reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci U S A 99 (2002) 13043-13048
19. Shaw P.X., Horkko S., Chang M.K., et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 105 (2000) 1731-1740
20. Briles D.E., Forman C., Hudak S., and Claflin J.L. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med 156 (1982) 1177-1185
21. Khallou-Laschet J., Tupin E., Caligiuri G., et al. Atheroprotective effect of adjuvants in apolipoprotein E knockout mice. Atherosclerosis (2005)
22. Lee W., Cosenza H., and Kohler H. Clonal restriction of the immune response to phosphorylcholine. Nature 247 (1974) 55-57
23. Nicoletti A., Kaveri S., Caligiuri G., Bariety J., and Hansson G.K. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest 102 (1998) 910-918
24. Briles D.E., Forman C., Hudak S., and Claflin J.L. The effects of subclass on the ability of antiphosphocholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae. J Mol Cell Immunol 1 (1984) 305-309
25. Briles D.E., Nahm M., Schroer K., et al. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J Exp Med 153 (1981) 694-705
26. Friedman P., Horkko S., Steinberg D., Witztum J.L., and Dennis E.A. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol concentration. J Biol Chem 277 (2002) 7010-7020
27. Nicoletti A., Caligiuri G., Tornberg I., Kodama T., Stemme S., and Hansson G.K. The macrophage scavenger receptor type A directs modified proteins to antigen presentation. Eur J Immunol 29 (1999) 512-521
28. Binder C.J., and Silverman G.J. Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin Immunopathol 26 (2005) 385-404
29. Reardon C.A., Miller E.R., Blachowicz L., et al. Autoantibodies to oxLDL fail to alter the clearance of injected oxLDL in apolipoprotein E-deficient mice. J Lipid Res 45 (2004) 1347-1354